Eating disorders and obesity : bridging clinical, neurobiological, and therapeutic perspectives
Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved..
Eating disorders (EDs) and obesity are complex health conditions sharing various risk and maintenance factors, intensified in cases of comorbidity. This review explores the similarities and connections between these conditions, examining different facets from a multidisciplinary perspective, among them comorbidities, metabolic and psychological factors, neurobiological aspects, and management and therapy implications. We aim to investigate the common characteristics and complexities of weight and EDs and explore their interrelationships in individuals who experience both. The rising prevalence of EDs in people with obesity necessitates integrated approaches to study this comorbidity and to identify and analyze both common and distinct features of these conditions. This review may offer new opportunities for simultaneous prevention and management approaches, as well as future lines of research.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:30 |
|---|---|
| Enthalten in: |
Trends in molecular medicine - 30(2024), 4 vom: 12. Apr., Seite 361-379 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Camacho-Barcia, Lucia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Binge eating |
|---|
| Anmerkungen: |
Date Completed 15.04.2024 Date Revised 15.04.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.molmed.2024.02.007 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM36975333X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM36975333X | ||
| 003 | DE-627 | ||
| 005 | 20240415233426.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240315s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.molmed.2024.02.007 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1376.xml |
| 035 | |a (DE-627)NLM36975333X | ||
| 035 | |a (NLM)38485648 | ||
| 035 | |a (PII)S1471-4914(24)00032-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Camacho-Barcia, Lucia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Eating disorders and obesity |b bridging clinical, neurobiological, and therapeutic perspectives |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.04.2024 | ||
| 500 | |a Date Revised 15.04.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved. | ||
| 520 | |a Eating disorders (EDs) and obesity are complex health conditions sharing various risk and maintenance factors, intensified in cases of comorbidity. This review explores the similarities and connections between these conditions, examining different facets from a multidisciplinary perspective, among them comorbidities, metabolic and psychological factors, neurobiological aspects, and management and therapy implications. We aim to investigate the common characteristics and complexities of weight and EDs and explore their interrelationships in individuals who experience both. The rising prevalence of EDs in people with obesity necessitates integrated approaches to study this comorbidity and to identify and analyze both common and distinct features of these conditions. This review may offer new opportunities for simultaneous prevention and management approaches, as well as future lines of research | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a binge eating | |
| 650 | 4 | |a eating disorders | |
| 650 | 4 | |a neurobiology | |
| 650 | 4 | |a obesity | |
| 650 | 4 | |a treatment | |
| 700 | 1 | |a Giel, Katrin Elisabeth |e verfasserin |4 aut | |
| 700 | 1 | |a Jiménez-Murcia, Susana |e verfasserin |4 aut | |
| 700 | 1 | |a Álvarez Pitti, Julio |e verfasserin |4 aut | |
| 700 | 1 | |a Micali, Nadia |e verfasserin |4 aut | |
| 700 | 1 | |a Lucas, Ignacio |e verfasserin |4 aut | |
| 700 | 1 | |a Miranda-Olivos, Romina |e verfasserin |4 aut | |
| 700 | 1 | |a Munguia, Lucero |e verfasserin |4 aut | |
| 700 | 1 | |a Tena-Sempere, Manuel |e verfasserin |4 aut | |
| 700 | 1 | |a Zipfel, Stephan |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández-Aranda, Fernando |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Trends in molecular medicine |d 2001 |g 30(2024), 4 vom: 12. Apr., Seite 361-379 |w (DE-627)NLM111960800 |x 1471-499X |7 nnns |
| 773 | 1 | 8 | |g volume:30 |g year:2024 |g number:4 |g day:12 |g month:04 |g pages:361-379 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.molmed.2024.02.007 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 30 |j 2024 |e 4 |b 12 |c 04 |h 361-379 | ||